944835-85-2: Axitinib Impurity B
It is an impurity of Axitinib. it is a potent and selective second-generation inhibitor of vascular endothelial growth factor receptors that are used in the first-line treatment of metastatic renal cell carcinoma
Additional information on CAS 944835-85-2
VL4110003
944835-85-2
C15H13N3OS
283.35
Axitinib
2-((1H-indazol-6-yl)thio)-N-methylbenzamide
Axitinib Impurity B; Kanamycin B; O-3-Amino-3-deoxy-?-D-glucopyranosyl-(1?6)-O-[2, 6-diamino-2, 6-dideoxy-?-D-glucopyranosyl-(1?4)]-2-deoxy-D-streptamine; 2'-Amino-2'-deoxykanamycin; Aminodeoxykanamycin; Beckanamycin; Bekanamycin; KDM; Kanendomycin; NK 1006; Nebramycin V; Nebramycin Factor 5;
Sonpavde, Guru, et al. “Axitinib for Renal Cell Carcinoma.” Expert Opinion on Investigational Drugs, vol. 17, no. 5, 30 Apr. 2008, pp. 741–748, 10.1517/13543784.17.5.741.
In-stock
Other products related to axitinib
CAS No. | Name of Impurity | Parent Drug | Catalogue No. |
---|